Rappley MD - Search Results

1

Low blood lead levels associated with clinically diagnosed attention-deficit/hyperactivity disorder and mediated by weak cognitive control.

Nigg JT, Knottnerus GM, Martel MM, Nikolas M, Cavanagh K, Karmaus W, Rappley MD. Nigg JT, et al. Among authors: rappley md. Biol Psychiatry. 2008 Feb 1;63(3):325-31. doi: 10.1016/j.biopsych.2007.07.013. Epub 2007 Sep 14. Biol Psychiatry. 2008. PMID: 17868654 Free PMC article.

2

Neuropsychological executive functions and DSM-IV ADHD subtypes.

Nigg JT, Blaskey LG, Huang-Pollock CL, Rappley MD. Nigg JT, et al. Among authors: rappley md. J Am Acad Child Adolesc Psychiatry. 2002 Jan;41(1):59-66. doi: 10.1097/00004583-200201000-00012. J Am Acad Child Adolesc Psychiatry. 2002. PMID: 11800208

3

Association and linkage of alpha-2A adrenergic receptor gene polymorphisms with childhood ADHD.

Park L, Nigg JT, Waldman ID, Nummy KA, Huang-Pollock C, Rappley M, Friderici KH. Park L, et al. Mol Psychiatry. 2005 Jun;10(6):572-80. doi: 10.1038/sj.mp.4001605. Mol Psychiatry. 2005. PMID: 15520832 Clinical Trial.

4

Family adversity in DSM-IV ADHD combined and inattentive subtypes and associated disruptive behavior problems.

Counts CA, Nigg JT, Stawicki JA, Rappley MD, von Eye A. Counts CA, et al. Among authors: rappley md. J Am Acad Child Adolesc Psychiatry. 2005 Jul;44(7):690-8. doi: 10.1097/01.chi.0000162582.87710.66. J Am Acad Child Adolesc Psychiatry. 2005. PMID: 15968238

5

The adrenergic receptor alpha-2A gene (ADRA2A) and neuropsychological executive functions as putative endophenotypes for childhood ADHD.

Waldman ID, Nigg JT, Gizer IR, Park L, Rappley MD, Friderici K. Waldman ID, et al. Among authors: rappley md. Cogn Affect Behav Neurosci. 2006 Mar;6(1):18-30. doi: 10.3758/cabn.6.1.18. Cogn Affect Behav Neurosci. 2006. PMID: 16869226

6

Attention-deficit/hyperactivity disorder in children and adolescents: interventions for a complex costly clinical conundrum.

Greydanus DE, Pratt HD, Sloane MA, Rappley MD. Greydanus DE, et al. Among authors: rappley md. Pediatr Clin North Am. 2003 Oct;50(5):1049-92, vi. doi: 10.1016/s0031-3955(03)00081-6. Pediatr Clin North Am. 2003. PMID: 14558681 Review.

7

Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children.

Rappley MD, Mullan PB, Alvarez FJ, Eneli IU, Wang J, Gardiner JC. Rappley MD, et al. Arch Pediatr Adolesc Med. 1999 Oct;153(10):1039-45. doi: 10.1001/archpedi.153.10.1039. Arch Pediatr Adolesc Med. 1999. PMID: 10520611

8

Patterns of psychotropic medication use in very young children with attention-deficit hyperactivity disorder.

Rappley MD, Eneli IU, Mullan PB, Alvarez FJ, Wang J, Luo Z, Gardiner JC. Rappley MD, et al. J Dev Behav Pediatr. 2002 Feb;23(1):23-30. doi: 10.1097/00004703-200202000-00005. J Dev Behav Pediatr. 2002. PMID: 11889348

9

Clinical practice. Attention deficit-hyperactivity disorder.

Rappley MD. Rappley MD. N Engl J Med. 2005 Jan 13;352(2):165-73. doi: 10.1056/NEJMcp032387. N Engl J Med. 2005. PMID: 15647579 Review. No abstract available.

10

The use of methylphenidate in Michigan.

Rappley MD, Gardiner JC, Jetton JR, Houang RT. Rappley MD, et al. Arch Pediatr Adolesc Med. 1995 Jun;149(6):675-9. doi: 10.1001/archpedi.1995.02170190085015. Arch Pediatr Adolesc Med. 1995. PMID: 7767425

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters